Immunocore's Tebentafusp Sole Winner In EU Fast-Track Stakes In June
European Medicines Agency's CHMP Rejected Four Out Of Five Requests
If Immuncore's tebentafusp is fast-tracked all the way through the centralized procedure at the EMA, it could be approved a few months earlier than it otherwise would be.
